PHARMATECA » №s2-17 / 2017

A.Yu. Ovchinnikov, S.S. Yegiyan, L.V. Akopyan LOCAL EMPIRIC TREATMENT OF ACUTE OTITIS EXTERNA	10-14
V.M. Svistushkin, L.A. Toporkova NATIONAL GUIDELINES FOR THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS OF THE UPPER RESPIRATORY TRACT: WHAT IS IMPORTANT TO KNOW FOR THERAPIST?	15-21
O.M. Kolesnikova, M.E. Malkova INTEGRATED APPROACH TO THE TREATMENT OF CHRONIC LARYNGITIS	22-25
K.V. Eremeeva, I.Yu. Meytel PRACTICAL IMPORTANCE OF SILVER-CONTAINING DRUGS FOR INFLAMMATORY ENT DISEASES	26-30
G.N. Nikiforova, E.I. Petrova INFLAMMATORY DISEASES OF THE PHARYNX – POSSIBILITIES OF TOPICAL ETIOPATOGENETIC THERAPY	31-34
E.A. Ushkalova, S.K. Zyryanov LEVOFLOXACIN: BENEFIT-RISK RATIO	36-42
P.A. Kochetkov, I.Yu Meytel, Zh.T. Godzhyan TRANSETHMOIDAL ORBITAL DECOMPRESSION ORBITS FOR A RARE FORM OF OPTIC NEUROPATHY: CASE REPORT	44-50
A.A. Svistunov (1), Yu.V. Olefir (2), G.S. Lebedev (1), K.A. Koshechkin (2) FORMATION OF A SINGLE INFORMATION SPACE IN THE SPHERE OF DRUG CIRCULATION	51-55